Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
EXPERIMENTAL HEMATOLOGY & ONCOLOGY(2024)
Key words
Cyclin-dependent kinase (CDK) inhibitors,Palbociclib,BCL2,Venetoclax,RB1,Mantle cell lymphoma (MCL)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined